IPO Profile: Second Sight Medical Products Inc

Medtech company, focused on eye-related degenerations, had a market cap of more than $537 million at end fo November

1 December 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.